MASSACHUSETTS GENERAL HOSPITAL
Department of Pharmacy
Department of Nursing
Critical Care
Generic Name: |
Methylprednisolone |
Trade Name: |
Solu-Medrol |
Action: |
Glucocorticoid |
Indications: |
Adrenal insufficiency Chronic obstructive pulmonary disease Cerebral edema Inflammatory diseases Transplant rejection Reduction of neurologic damage secondary to spinal Cord injury Reduction of allergenic reactions to exogenous substances Asthma exacerbations |
Administration Guidelines: |
|
Usual Dosage Range and Route: |
Maintenance : 24 hour cumulative : Spinal cord injury : Transplant rejection : Reduction of allergenic drug response : |
Standard Concentration: (Questions should be referred to the Pharmacist) |
Single doses less than or equal to 250 mg, regardless of the indication, may be administered by IV push according to nursing and pharmacy policies. Single doses exceeding 250 mg may be prepared as an infusion. 1000mg/ 100mL 500mg/ 50mL Microinfusion concentration for pulse dosing >250mg: 1000mg/50ml, 500mg/25ml |
EW Standard |
Single doses less than or equal to 250 mg, regardless of the indication, may be administered by IV push according to nursing and pharmacy policies.
Single doses exceeding 250 mg may be prepared as an infusion: 1000mg/ 100mL 500mg/ 100mL Pharmacy mixes ALL maintenance doses for spinal cord injury. Pharmacy mixes load when requested. |
Special Considerations: |
- Monitor serum glucose, electrolytes, and osmolality - Prolonged administration may require tapering of dose to discontinue therapy - May require anti-hyperglycemic therapy in susceptible patients - Dosage range may vary depending on disease state - The use of methylprednisolone for the reduction of allergic reactions requires administration at 12 and 2 hours pre-exposure to the causative agent to be effective |
Precautions and Side Effects: |
- Electrolyte imbalance - CNS disturbances, hallucinations - Gastrointestinal disturbances - Adrenal suppression - Hyperglycemia |
rev: 04/08